Leveraging Innate Immunity as a First Line Defense against SARS-CoV-2. Hoagland, Møller et al.
Published: 12 January 2021| Version 1 | DOI: 10.17632/hstgdwvz9f.1
Additional supplemental items for the publication
Icahn School of Medicine at Mount Sinai
High-Throughput Sequencing, Hamster, Severe Acute Respiratory Syndrome Coronavirus 2